Qianhai Health Holdings Income Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	553.58	519.7	961.29	1,962	283.4	760.72
Revenue Growth (YoY)	-40.37%	-45.94%	-51.00%	592.21%	-62.75%	29.42%
Cost of Revenue	552.65	490.03	996.89	2,123	278.78	719.09
Gross Profit	0.93	29.67	-35.6	-161.52	4.62	41.63
Selling, General & Admin	17.33	15.49	16.75	19.36	20.67	25.31
Other Operating Expenses	-	-	-	-	-	13.98
Operating Expenses	17.59	15.75	16.58	2.43	20.67	39.29
Operating Income	-16.66	13.92	-52.18	-163.95	-16.06	2.33
Interest Expense	-0.04	-0.02	-0.04	-0.03	-0.51	-1.77
Interest & Investment Income	0.16	0.24	0.07	0.1	0.12	0.14
Earnings From Equity Investments	-	-	-	-	-	-1.64
Currency Exchange Gain (Loss)	-0.15	-0.18	-1.55	1.07	1.26	0.72
Other Non Operating Income (Expenses)	-40.53	-60.4	1	-93.2	-	-
EBT Excluding Unusual Items	-57.21	-46.44	-52.71	-256.01	-15.18	-0.22
Gain (Loss) on Sale of Assets	51.9	51.9	-	21.95	14.3	-1.39
Asset Writedown	-4.15	-4.15	-	-	-	-
Other Unusual Items	-	-	-	0.36	-	0.81
Pretax Income	-9.46	1.31	-52.71	-233.7	-0.89	-0.8
Earnings From Continuing Operations	-9.46	1.31	-52.71	-233.7	-0.89	-0.8
Net Income	-9.46	1.31	-52.71	-233.7	-0.89	-0.8
Net Income to Common	-9.46	1.31	-52.71	-233.7	-0.89	-0.8
Shares Outstanding (Basic)	169	169	169	169	169	169
Shares Outstanding (Diluted)	169	169	169	169	169	169
Shares Change (YoY)	-	-	-	0.08%	0.01%	-
EPS (Basic)	-0.06	0.01	-0.31	-1.38	-0.01	-0.00
EPS (Diluted)	-0.06	0.01	-0.31	-1.38	-0.01	-0.00
Free Cash Flow	25.21	4.19	0.86	-5.26	-44.19	-70.9
Free Cash Flow Per Share	0.15	0.03	0.01	-0.03	-0.26	-0.42
Gross Margin	0.17%	5.71%	-3.70%	-8.23%	1.63%	5.47%
Operating Margin	-3.01%	2.68%	-5.43%	-8.36%	-5.67%	0.31%
Profit Margin	-1.71%	0.25%	-5.48%	-11.91%	-0.31%	-0.11%
Free Cash Flow Margin	4.55%	0.81%	0.09%	-0.27%	-15.59%	-9.32%
EBITDA	-15.3	15.64	-50.46	-162.22	-14.33	4.46
EBITDA Margin	-2.76%	3.01%	-5.25%	-8.27%	-5.06%	0.59%
D&A For EBITDA	1.36	1.72	1.72	1.72	1.73	2.12
EBIT	-16.66	13.92	-52.18	-163.95	-16.06	2.33
EBIT Margin	-3.01%	2.68%	-5.43%	-8.36%	-5.67%	0.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.